Penserra Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,104
Closed -$211K 1340
2023
Q2
$211K Buy
+3,104
New +$200K ﹤0.01% 777
2021
Q4
Sell
-1,030
Closed -$73K 1505
2021
Q3
$73K Buy
1,030
+25
+2% +$1.55K ﹤0.01% 929
2021
Q2
$51K Buy
1,005
+105
+12% +$3.28K ﹤0.01% 995
2021
Q1
$22K Sell
900
-15
-2% -$282 ﹤0.01% 961
2020
Q4
$10K Buy
915
+577
+171% +$6.82K ﹤0.01% 926
2020
Q3
$3K Buy
+338
New +$4.07K ﹤0.01% 888

Other funds holding PRTA

Penserra Capital Management's PRTA Position: Q3 2023 in Review

Penserra Capital Management sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 3,104 shares — an estimated $211K sold.

Penserra Capital Management first reported a position in PRTA in Q3 2020 and held it in 6 quarters. The position peaked at $211K in Q2 2023. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

  • Penserra Capital Management reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
  • Penserra Capital Management sold 3,104 Prothena Corp shares in Q3 2023, an estimated $211K.
  • Penserra Capital Management first reported a position in Prothena Corp in Q3 2020 and held it in 6 quarters.
  • Penserra Capital Management's Prothena Corp position peaked at $211K in Q2 2023.
  • 186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Penserra Capital Management's 13F filing for Q3 2023, filed 15 Nov 2023.